https://www.selleckchem.com/pr....oducts/pimicotinib.h
Thyroid nodule size is one of the key parameters that determines the operative approach for thyroid carcinoma. It is necessary to evaluate the influence of nodule size on the aggressiveness of thyroid carcinoma. The eighth edition of staging system has updated the prognostic age cutoff from 45 to 55 years old. It is needed to re-evaluate the difference in aggressiveness of thyroid carcinoma between younger (55 years old) and older (≥55 years old) patients. Importantly, whether the influence of nodule size on the aggressiveness o
Like
Comment
Share
